Cover Image

How to reduce a risk of venous thromboembolism while taking combined oral contraceptives

The review presents data on the evolution of combined oral contraceptives (COCs), related most frequent and dangerous side effects including venous thromboembolism (VTE). The issue of VTE upon administration of COCs is highlighted, and the risks of such complication in patients receiving hormonal co...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. O. Bitsadze (Author), J. Kh. Khizroeva (Author), A. G. Solopova (Author), M. V. Kvaratskheliia (Author), D. Yu. Zabolotnaya (Author), Z. Xiaoxia (Author), M. V. Tretyakova (Author), V. I. Tsibizova (Author), N. R. Gashimova (Author), K. N. Grigoreva (Author), M. A. Gileva (Author), A. S. Shkoda (Author), J.-Ch. Gris (Author), A. D. Makatsariya (Author)
Format:	Book
Published:	IRBIS LLC, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022)

Intrauterine activation of the fetal immune system in response to maternal COVID-19
by: N. R. Gashimova, et al.
Published: (2023)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023)

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023)

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
by: N. R. Gashimova, et al.
Published: (2023)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022)

Platelets, thrombo-inflammation and cancer
by: E. V. Slukhanchuk, et al.
Published: (2022)

What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas?
by: V. O. Bitsadze, et al.
Published: (2023)

Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
by: A. D. Makatsariya, et al.
Published: (2021)

Antiphospholipid antibodies as a potential factor of tumor progression
by: Z. D. Aslanova, et al.
Published: (2024)

Metalloproteinases as biochemical markers of pregnancy pathology
by: K. N. Grigorieva, et al.
Published: (2022)

Pregnancy and Zika virus
by: T. V. Startseva, et al.
Published: (2020)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020)

Septic shock
by: V. O. Bitsadze, et al.
Published: (2020)

Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms
by: E. V. Slukhanchuk, et al.
Published: (2022)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022)

Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers
by: J. H. Khizroeva, et al.
Published: (2020)

Features of nervous system damage in antiphospholipid syndrome
by: O. N. Voskresenskaya, et al.
Published: (2021)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022)

Dysregulated platelet function in COVID-19 patients
by: N. R. Gashimova, et al.
Published: (2023)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021)

The role of platelets in antiviral immunity
by: E. V. Slukhanchuk, et al.
Published: (2022)

The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients
by: A. D. Makatsariya, et al.
Published: (2024)

Macrophage activation syndrome in COVID-19
by: K. N. Grigorieva, et al.
Published: (2021)

Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology
by: A. D. Makatsariya, et al.
Published: (2021)

THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES
by: S. V. Akinshina, et al.
Published: (2016)

Homocysteine, cancer and oncothrombosis
by: V. O. Bitsadze, et al.
Published: (2023)

Female magnesium deficiency and its management: review of current knowledge
by: A. D. Makatsariya, et al.
Published: (2024)

Features of the novel coronavirus infection in cancer patients
by: A. D. Makatsariya, et al.
Published: (2022)

Neutrophil extracellular traps-associated markers in malignant neoplasms of the female reproductive system after surgical treatment and adjuvant chemotherapy
by: E. V. Slukhanchuk, et al.
Published: (2023)

HELLP-SYNDROME
by: A. D. Makatsariya, et al.
Published: (2016)

An impact of neutrophil extracellular traps to the prothrombotic state and tumor progression in gynecological cancer patients
by: E. V. Slukhanchuk, et al.
Published: (2023)

Multiple pregnancy in fine arts
by: N. A. Makatsariya, et al.
Published: (2023)

Management of antithrombin III deficiency in pregnancy: a representative case and a literature review
by: S. V. Akinshina, et al.
Published: (2021)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021)

Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022)